FDA Cleared Migraine Pain Reduction
with Patented Anti-Clenching Technology
also Makes Teeth-Grinding Impossible
Migraine Pain Prevention now available without a prescription
Migraine is the #1 disability in adults under 50 years of age. Other than the specific headache pain symptoms that the migraine suffer describes, there are no objective abnormalites in the migraine patient, except for one particular ability: on average, migraine sufferers can clench their jaw with twice the force as asymptomatic controls.
While it was first thought nocturnal jaw clenching was in response to their pain, it was found that chronic headache sufferers clench their jaw during sleep with 14x the intensity as asymptomatic controls.
For the chronic migraine and headache sufferer,
intense jaw clenching typically occurs just before waking.
The ClenchGuard (a fully do-it-yourself mouthpiece kit) and MigraineGuard (available soon: a custom-made device from a professional dental lab using an at-home impression kit) are the first OTC anti-clenching technology dental devices cleared by the FDA for: the treatment and prevention of jaw-clenching and TMD (temporomandibular disorders); and the reduction of medically diagnosed migraine pain.
Both devices prevent the pathologic nocturnal clenching intensity that produces the nociceptive (negative) trigeminal input known to increase migraine activity. In doing so, the ClenchGuard and MigraineGuard both also provide the ideal oral device design that make teeth-grinding impossible.
Waking with a headache becomes part of the sufferer's daily private existence
How traditional dental mouthpieces miss the mark
When a patient is diagnosed with "nocturnal parafunction", that is, jaw clenching and/or teeth grinding (together known as "bruxism"), a dental protective splint, or "nightguard", is prescribed. The splint has two objectives: to protect the teeth from the damage of grinding; and to provide a balanced biting surface, so as to stabilize the jaw joints during clenching. However, the one thing the splint cannot do is prevent the parafunctional activity. If fact, the presence of the splint can allow clenching intensity to increase beyond the already pathologic level.
Providing a perfected clenching surface allows for increased clenching intensity
ClenchGuard and MigraineGuard employ patented
"anti-clenching" technology making teeth-grinding impossible
The ClenchGuard (shown here) provides for an anterior mid-line dome shape incorporated into an upper mouthpiece, which opposes a flat surface lower mouthpiece. This patented design prevents the posterior surfaces from touching (which is required to achieve pathologic clenching intensity).
While minimizing clenching intensity, the anterior dome also provides for a "balanced" bite (zero on one side and zero on the other), thereby maintaining stable jaw joints, while making grinding impossible.
Presented at the 2018 International Migraine Trust in London, the ClenchGuard and MigraineGuard design has shown to provide a profound improvement in Quality of Life for 89% of chronic migraine sufferers. and just recently published in the BMC Journal of Neurology.